Working… Menu

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03355976
Recruitment Status : Recruiting
First Posted : November 29, 2017
Last Update Posted : August 3, 2020
Bristol-Myers Squibb
Rhode Island Hospital
The Miriam Hospital
Brown University
Women and Infants Hospital of Rhode Island
Information provided by (Responsible Party):
Don Dizon, Brown University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2023